Clinical Trials Directory

Trials / Completed

CompletedNCT04982952

Contingency Management for Smoking Cessation

Randomized Trial of a Contingency Management Smoking Cessation Intervention for Homeless Adults

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
83 (actual)
Sponsor
University of California, San Francisco · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The prevalence of smoking in the homeless population (70%) is over 4 times that of the general population (15%). Homeless adults have not experienced similar declines in tobacco use as the general population has over the past three decades. Homeless adults are interested in smoking cessation and make quit attempts, but are less successful in quitting smoking than the general population. Trials of group behavioral counseling and pharmacotherapy for smoking cessation have not led to substantial long-term abstinence (i.e., abstinence for 6 months or more), suggesting that these interventions alone are insufficient to improve quit rates among homeless adults. Many homeless adults seek health care in safety net clinics; these clinics could bring cessation interventions to scale. Contingency management is a powerful behavior change intervention that reinforces positive health behaviors through the provision of modest incentives (e.g., cash). In this pilot randomized controlled trial, the investigator will test the feasibility and acceptability of a contingency management intervention that provides incentives for smoking cessation for people experiencing homelessness.

Detailed description

In this pilot randomized controlled trial (RCT), the investigator will (1) adapt a known-efficacious extended CM cessation intervention to a novel population and setting, with the ultimate goal of increasing long-term abstinence among homeless adults seeking care in safety net health clinics, (2) develop a corresponding RCT protocol, and (3) conduct a pilot RCT to assess the feasibility and acceptability of the RCT. If the pilot RCT is feasible and acceptable, the investigator will test the adapted intervention in a subsequently-funded, full-scale RCT. Primary Objectives: Assess feasibility and acceptability of a CM intervention through: 1. Measuring biochemically-verified point prevalence abstinence at 6 months follow-up. 2. Measuring participant adherence to the protocol. 3. Gathering information on the number of visits attended. 4. Assessing the retention protocol. Secondary Objectives Assess feasibility and acceptability of a CM intervention through: 1. Biochemically-verified 7-day point months follow-up at 3 months. 2. Prolonged abstinence at 3 months and 6 months follow-up. 3. Point-prevalent abstinence at 12 months

Conditions

Interventions

TypeNameDescription
BEHAVIORALContingency Management - IncreasingIncreasing incentive payment for abstinent participant
BEHAVIORALFixed paymentsFixed payments for attending study visits

Timeline

Start date
2021-11-09
Primary completion
2024-06-30
Completion
2024-06-30
First posted
2021-07-29
Last updated
2024-12-05

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04982952. Inclusion in this directory is not an endorsement.